Top compounds associated with response to OGT


Feature Type Standardized
Nominal ANOVA
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.12 0.007
mRNA Methotrexate FIMM pan-cancer AAC 0.39 0.007
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.007
mRNA etomoxir CTRPv2 pan-cancer AAC 0.11 0.007
mRNA AR-42 GDSC1000 pan-cancer AAC 0.091 0.007
mRNA paclitaxel GDSC1000 pan-cancer AAC 0.16 0.007
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.099 0.008
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.009
mRNA PD-0325901 CCLE pan-cancer AAC -0.13 0.009
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.099 0.01
Download CSV